Josh

About Josh Rodriguez

Joshua Rodriguez is the owner and founder of CNA Finance. He is also a partner here at Modest Money. His analysis has been featured on Investing.com, Yahoo! Finance, Google Finance, Google News, and many others. To connect with Joshua, follow him on Twitter @CNAFinance.
Monster Digital (MSDI) Stock: Gaining on Management Shakeup
  • Monster Digital (MSDI) Stock: Gaining on Management Shakeup

Monster Digital (MSDI) Stock: Gaining on Management Shakeup

By |February 7th, 2017|

Monster Digital Inc (NASDAQ: MSDI)

Monster Digital is having a pretty strong day in the market today, and for good reason. Early this morning, the company published a press release announcing changes to management. The shakeup is refueling bullish opinions surrounding the company. Below, we’ll talk about the management shakeup, how the stock is reacting, […]

How a Catalyst Turns into Dollar Signs
  • How a Catalyst Turns into Dollar Signs

How a Catalyst Turns into Dollar Signs

By |February 6th, 2017|

Those of us that have been around the block in the investing world know that there are several important signals for investors to watch. One of the most important of these is known as the catalyst. At the end of the day, catalysts often turn into dollar signs. That is, if you know how […]

Aytu BioScience (AYTU) Stock: Putting The Pieces Together
  • Aytu BioScience (AYTU) Stock: Putting The Pieces Together

Aytu BioScience (AYTU) Stock: Putting The Pieces Together

By |February 3rd, 2017|

Aytu BioScience Inc (OTCMKTS: AYTU)

When it comes to the world of micro-caps, one of the biggest problems tends to be communication with investors. Small companies just don’t seem to update their investors quite as much as the larger companies. However, Aytu BioScience seems to be breaking that mold. In fact, in just the 2 […]

Ritter Pharmaceuticals (RTTR) Stock: Is It a Buy?
  • Ritter Pharmaceuticals (RTTR) Stock: Is It a Buy?

Ritter Pharmaceuticals (RTTR) Stock: Is It a Buy?

By |January 30th, 2017|

Ritter Pharmaceuticals Inc (NASDAQ: RTTR)

Recently, one of my followers reached out through email and asked what I thought of RTTR. To be honest, when they did, I had never heard of the stock before. However, I decided to do some digging to see if I could offer something of value with regard to insight […]

Catalyst Biosciences (CBIO) Stock: Announces a Coming Catalyst
  • Catalyst Biosciences (CBIO) Stock: Announces a Coming Catalyst

Catalyst Biosciences (CBIO) Stock: Announces a Coming Catalyst

By |January 27th, 2017|

Catalyst Biosciences Inc (NASDAQ: CBIO)

Catalyst Biosciences is having a relatively strong day in the market today, and for good reason. The company released a PR early this morning that announced coming presentations. The presentations will surround the company’s candidates with hematology indications. Below, we’ll talk about the coming catalyst, what we’re seeing from CBIO […]

Cellectar Biosciences (CLRB) Stock: Gaining Big on Patent News
  • Cellectar Biosciences (CLRB) Stock: Gaining Big on Patent News

Cellectar Biosciences (CLRB) Stock: Gaining Big on Patent News

By |January 24th, 2017|

Cellectar Biosciences Inc (NASDAQ: CLRB)

Cellectar Biosciences is having an incredibly strong day in the market today, and for good reason. In pre-market hours, it was announced that the company has been awarded a new patent, sending the stock spiking upward dramatically. Below, we’ll talk about the patent, what we saw in the market as […]

BioLineRx (BLRX) Stock: An Interesting Opportunity in the Making?
  • BioLineRx (BLRX) Stock: An Interesting Opportunity in the Making?

BioLineRx (BLRX) Stock: An Interesting Opportunity in the Making?

By |January 23rd, 2017|

BioLineRx Ltd (NASDAQ: BLRX)

One of the things I love about my job is the fact that I tend to find opportunities in the market early on. This one, BioLineRx was brought to my attention by a friend at an IR firm. After a quick conversation, I decided that it was time to start doing […]

TransDigm Group (TDG) Stock: Falling Apart as Trump Takes Office
  • TransDigm Group (TDG) Stock: Falling Apart as Trump Takes Office

TransDigm Group (TDG) Stock: Falling Apart as Trump Takes Office

By |January 20th, 2017|

TransDigm Group Incorporated (NYSE: TDG)

TransDigm Group is having an incredibly hard time in the market today. When the trading session opened for the day, the stock was already trading slightly in the red, but no one expected what we would see just 15 minutes in. A report was published by Citron Research that sent […]

Trading With The News: A Surefire Strategy
  • Trading With The News: A Surefire Strategy

Trading With The News: A Surefire Strategy

By |January 20th, 2017|

If you’re a trader, whether a beginner or a professional, you know the importance of strategy. At the end of the day, your trading strategy is the what, when, and why, of just about every trade you will make in the market. Throughout the years, I’ve tried various strategies; some successfully, some not so […]

Regulation A+ Is Changing The Game In The Investment Space
  • Regulation A+ Is Changing The Game In The Investment Space

Regulation A+ Is Changing The Game In The Investment Space

By |January 19th, 2017|

If you’re an investor, you may or may not have heard about new SEC regulation known as Regulation A+. However, it is likely a regulation that will drastically change the game for those looking to get involved in smaller companies that offer tremendous growth opportunities. Today, we’ll talk about what Regulation A+ is, a […]